NEULANDLAB has declared results for the period ended Jun 2021.
Quarterly Results
[s2If !current_user_can(access_s2member_level1)] Register and Login below to read result analysis [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]
- Sales for period ended Jun 2021 is Rs 200.89 cr compared to Rs 205.42 cr for period ended Jun 2020, a fall of 2.2%
- Operating Profits reported at Rs 25.68 cr for period ended Jun 2021 vis-vis 33.84 for period ended Jun 2020 .
- Operating Margins contracted -369.0 bps for period ended Jun 2021 vis-vis Jun 2020 .
- The EPS for Jun 2021 was Rs 6.8 compared to Rs 13.48 for previous quarter ended Mar 2021 and Rs 11.82 for Jun 2020
- The stock is trading at Rs 1962.00 and a market cap of Rs 2517 cr
[/s2If]
Trading Chart
Further analysis and Full Company Research with investing scores is available here: NEULANDLAB